![]() |
市场调查报告书
商品编码
1619061
微生物组定序服务市场规模、份额、成长分析(按服务、技术、地区)- 产业预测,2024-2031 年Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Service (Sample Preparation, Sequencing and Library Preparation), By Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL)), By Region - Industry Forecast 2024-2031 |
微生物组定序服务的全球市场规模在2022年估值为13.7亿美元,从2023年的15.2亿美元增长到2031年的34.8亿美元,并预计在预测期内增长(2024年-预计将以复合年成长率成长) 2031 年将成长 10.9%)。
由于基因技术的进步、人们对人类微生物组在健康中的作用的认识不断增强以及对个人化医疗的需求不断增长,微生物组定序服务市场正在经历快速增长。强调微生物群落与整体健康之间关係的研究激发了消费者了解自身微生物组的兴趣,并增加了对定序服务的需求。随着针对各种疾病的基于微生物组的药物的出现,此类服务在治疗中变得至关重要。结合转录组学、代谢体学和基因组资料的多体学方法的流行正在提高研究成果并加强细菌与人类健康之间的复杂联繫。此外,需要生物资讯学的进步来处理不断增加的微生物基因组资料,为准确诊断和增强在环境研究和农业中的应用铺平道路。
Global Microbiome Sequencing Services Market size was valued at USD 1.37 billion in 2022 and is poised to grow from USD 1.52 billion in 2023 to USD 3.48 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).
The market for microbiome sequencing services is experiencing rapid growth driven by advancements in genetic technology, increased awareness of the human microbiome's role in health, and a rising demand for personalized medicine. Research highlighting the relationship between microbial communities and overall health fuels consumer interest in understanding their own microbiomes, thus elevating the need for sequencing services. These services are becoming integral in medical treatments, with microbiome-based medications for various diseases emerging. The popularity of multi-omics approaches-combining transcriptomics, metabolomics, and genomic data-enhances research outcomes, reinforcing the intricate connection between bacteria and human health. Additionally, advancements in bioinformatics are needed to process growing microbial genomic data, paving the way for accurate diagnoses and enhancing applications in environmental studies and agriculture.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microbiome Sequencing Services Market Segmental Analysis
Global Microbiome Sequencing Services Market is segmented by service, technology, application, end user and region. Based on service, the market is segmented into Sample Preparation, Sequencing and Library Preparation, and Data Analysis. Based on technology, the market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing and others. Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Microbiome Sequencing Services Market
The global microbiome sequencing services market is significantly driven by the rising demand for personalized medicine. As healthcare increasingly shifts towards tailored approaches for individuals, microbiome analysis becomes essential in understanding the unique composition of microorganisms within each patient. This targeted analysis aids in the accurate diagnosis and effective management of various health conditions, enhancing treatment outcomes. Consequently, the growing emphasis on personalized healthcare solutions is fueling the expansion of the microbiome sequencing services market, as more healthcare professionals seek to incorporate these advanced analytical techniques into their practices to optimize patient care.
Restraints in the Global Microbiome Sequencing Services Market
A major constraint facing the Global Microbiome Sequencing Services market is the prohibitive cost associated with sequencing. Despite advancements in technology, the expenses related to sequencing equipment, reagents, and data analysis remain substantial. This financial barrier poses challenges for smaller research institutions and clinics, making it difficult for them to access and implement these services. As a result, the high costs hinder widespread adoption and utilization of microbiome sequencing, ultimately stifling the growth prospects of the market and limiting opportunities for innovation and research in the field.
Market Trends of the Global Microbiome Sequencing Services Market
The global microbiome sequencing services market is experiencing a significant trend toward the integration of Artificial Intelligence (AI) and machine learning technologies. This shift enhances the analysis of complex microbiome data, facilitating a deeper understanding of microbial interactions and their implications for health and disease prevention. As AI-driven tools become more prevalent, they enable researchers and healthcare professionals to derive actionable insights from vast amounts of sequencing data, leading to improved therapeutic strategies and personalized medicine approaches. Consequently, the demand for advanced microbiome analysis services is anticipated to surge, reflecting a broader movement towards data-driven solutions in life sciences and healthcare sectors.